abstract |
The invention provides oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3'and/or 5'-terminal groups. The described compounds are useful for the treatment of diseases in which inhibition of protein expression or correction of abnormal mRNA splice products provides a beneficial therapeutic effect. |